Product NDC: | 25021-823 |
Proprietary Name: | Haloperidol Lactate |
Non Proprietary Name: | haloperidol lactate |
Active Ingredient(s): | 5 mg/mL & nbsp; haloperidol lactate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-823 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200742 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111024 |
Package NDC: | 25021-823-10 |
Package Description: | 1 VIAL in 1 CARTON (25021-823-10) > 10 mL in 1 VIAL |
NDC Code | 25021-823-10 |
Proprietary Name | Haloperidol Lactate |
Package Description | 1 VIAL in 1 CARTON (25021-823-10) > 10 mL in 1 VIAL |
Product NDC | 25021-823 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | haloperidol lactate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20111024 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | HALOPERIDOL LACTATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |